Remove Leveraging Remove Mergers and Acquisitions Remove Portfolios
article thumbnail

Continuation funds emerge as a key strategy in private equity’s long-term growth playbook

Private Equity Insights

Private equity firms are increasingly using continuation funds to extend ownership of portfolio companies. Continuation funds also underline private equitys commitment to supporting portfolio companies through economic cycles. Source: Mergers & Acquisitions Can’t stop reading?

article thumbnail

Akin adds Partner to PE transactions practice

Private Equity Wire

Alperovich has extensive experience advising private equity sponsors and their portfolio companies on a broad range of transactions, including mergers and acquisitions, leveraged buyouts, minority and growth investments, joint ventures, carve-outs and divestitures, restructurings, SPACs and de-SPACs, and investments in general partners.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Evolving Playbook: Expert-Led Operational Enhancements in Private Equity

Private Equity Professional

Over the years, private equity has shifted from a focus on leverage and financial engineering to an ever-increasing emphasis on creating value through operational improvements within their portfolio companies. Multiple mergers and acquisitions had created operational inconsistencies within the business.

article thumbnail

Investing $100,000 in These 3 Ultra-High-Yield Dividend Stocks Could Bring $10,000 in Passive Income to Your Portfolio in 2024

The Motley Fool

For this reason, BDCs tend to garner a lot of attention from investors looking to supplement their portfolio with some dividend income. Investing $100,000 in the three ultra-high-yield BDCs discussed below could generate $10,000 of passive income for your portfolio this year. Hercules Capital: 11.5% Image source: Getty Images.

article thumbnail

Pharma Giants Combine Forces to Fight New M&A Rules

The Motley Fool

With a looming overhaul of US merger-and-acquisition law set to reshape the economics of the M&A-heavy pharmaceutical industry, 31 of its biggest players -- including Merck, Amgen, Abbvie, and Gilead -- formed an alliance to fight the reforms. billion merger with Horizon Therapeutics. Meet the anti-antitrust coalition.

article thumbnail

1 Warren Buffett Stock Down 62% to Buy in 2024 and Hold

The Motley Fool

After all, he's owned it since he helped arrange a merger to create the entity in 2015. The merger was worth roughly $45 billion, creating a food giant that owns such famous brands as Kraft, Heinz, Oscar Meyer, Kool-Aid, Jell-O, Capri-Sun, and more. However, the merger also loaded up the new entity with debt. Is it stubbornness?

article thumbnail

Why I Keep Buying More Shares of This Amazing 5%-Yielding Dividend Stock

The Motley Fool

It's one of only eight REITs in the S&P 500 with two A3/A- credit ratings or better, thanks to its lower leverage ratios and the quality of its portfolio. The REIT's conservative financial profile gives it the flexibility to continue expanding its real estate portfolio so that it can keep increasing its high-yielding dividend.